PABFX
Price
$17.88
Change
-$0.17 (-0.94%)
Updated
Jun 13 closing price
Net Assets
999.73M
RLBFX
Price
$35.69
Change
-$0.31 (-0.86%)
Updated
Jun 13 closing price
Net Assets
246.53B
Interact to see
Advertisement

PABFX vs RLBFX

Header iconPABFX vs RLBFX Comparison
Open Charts PABFX vs RLBFXBanner chart's image
PGIM Balanced Z
Price$17.88
Change-$0.17 (-0.94%)
VolumeN/A
Net Assets999.73M
American Funds American Balanced R5
Price$35.69
Change-$0.31 (-0.86%)
VolumeN/A
Net Assets246.53B
PABFX vs RLBFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PABFX vs. RLBFX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABFX is a Buy and RLBFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 247B vs. PABFX (1B). PABFX pays higher dividends than RLBFX: PABFX (2.35) vs RLBFX (2.18). PABFX was incepted earlier than RLBFX: PABFX (32 years) vs RLBFX (23 years). PABFX (0.84) is less costly to investors than RLBFX (0.29). PABFX is a more actively managed with annual turnover of: 107.00 vs. RLBFX (44.00). PABFX has a lower initial minimum investment than RLBFX: PABFX (0) vs RLBFX (250). RLBFX annual gain was more profitable for investors over the last year : 5.61 vs. PABFX (2.12). RLBFX return over 5 years is better than : 40.09 vs. PABFX (27.98).
PABFXRLBFXPABFX / RLBFX
Total Expense Ratio0.780.29269%
Annual Report Gross Expense Ratio0.840.29290%
Fund Existence32 years23 years-
Gain YTD3.2304.56071%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1B247B0%
Annual Yield % from dividends2.352.18108%
Returns for 1 year2.125.6138%
Returns for 3 years29.7033.6688%
Returns for 5 years27.9840.0970%
Returns for 10 years35.2760.5158%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XENE32.76-0.04
-0.12%
Xenon Pharmaceuticals
CELZ2.18-0.02
-0.91%
Creative Medical Technology Holdings
MEDP298.25-5.75
-1.89%
Medpace Holdings
PRPH0.33-0.01
-2.56%
ProPhase Labs
MLAB97.10-2.79
-2.79%
Mesa Laboratories